Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
crispr-cas9
3
×
detroit blog main
detroit top stories
fda
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
3
×
cancer
cancer immunotherapy
clinical trials
deals
eidos therapeutics
eli lilly
gene editing
glaxosmithkline
incyte
indiana blog main
indiana top stories
What
roundup
bio
crispr
days
ahead
alliance
ambien
american
annual
asco
attendees
attention
big
biotech
bosley's
bosley’s
bridge
bristol
bucks
buy
calls
camp’s
cancer
cas
cash
ceo
changing
chicago
city
clinical
color
combinations
community’s
crime
departure
drug
editas
exit
expanding
focus
Language
unset
Current search:
crispr-cas9
×
" wisconsin top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More